Multiple sclerosis: open trials in Lithuania

• 2023-504358-36-00

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement

  Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius

  Registry updated 2026-10-28

• NCT07299019

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas

  Registry updated 2026-10-27

• 2024-512914-16-00

  A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis

  Trial Treatment · Phase 3 · Amgen Inc.

  Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas · Klaipedos universiteto ligonine VšĮ, Klaipeda

  Registry updated 2026-10-20

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Kaunas

  Registry updated 2026-10-13

• 2025-521546-23-00

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas · Klaipedos universiteto ligonine VšĮ, Klaipeda · Respublikine Siauliu ligonine VšĮ, Siauliai

  Registry updated 2026-07-30

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error